Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengjie Rui

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Pharmaceuticals (Basel, Switzerland)|August 28, 2025
Discovery of Small-Molecule PD-L1 Inhibitors via Virtual Screening and Their Immune-Mediated Anti-Tumor EffectsChunlai Feng, Yingying Ge, Siqi Wang, et al.
Drug Delivery|December 17, 2025
Tumor microenvironment-responsive conformational activation of apoA-I mimetic peptides for targeted cancer therapyMengjie Rui, Lei Fang, Mengfei Jia, et al.
International Journal of Biological Macromolecules|September 10, 2023
Design and evaluation of α-helix-based peptide inhibitors for blocking PD-1/PD-L1 interactionMengjie Rui, Wen Zhang, Ke Mi, et al.
Frontiers in Pharmacology|January 22, 2025
Artificial intelligence-driven identification and mechanistic exploration of synergistic anti-breast cancer compound combinations from <i>Prunella vulgaris</i> L.-<i>Taraxacum mongolicum</i> Hand.-Mazz. herb pairChunlai Feng, Jiaxi Cheng, Mengqiu Sun, et al.
AAPS Pharmscitech|February 11, 2025
Computational Design and Optimization of Multi-Compound Multivesicular Liposomes for Co-Delivery of Traditional Chinese Medicine CompoundsMengjie Rui, Yali Su, Haidan Tang, et al.
International Journal of Biological Macromolecules|June 20, 2024
In silico screening and in vivo experimental validation of 15-PGDH inhibitors from traditional Chinese medicine promoting liver regenerationChunlai Feng, Chunxue Qiao, Wei Ji, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Identification of Potential RBPJ-Specific Inhibitors for Blocking Notch Signaling in Breast Cancer Using a Drug Repurposing StrategyMengjie Rui, Min Cai, Yu Zhou, et al.
AAPS Pharmscitech|February 1, 2022
A Strategy for the Effective Optimization of Pharmaceutical Formulations Based on Parameter-Optimized Support Vector Machine ModelSiqi Wang, Jianping Yang, Hengwei Chen, et al.
International Journal of Pharmaceutics|June 14, 2017
Tumor-specific delivery of doxorubicin through conjugation of pH-responsive peptide for overcoming drug resistance in cancerChunlai Feng, Mengjie Rui, Haijun Shen, et al.
Frontiers in Pharmacology|July 24, 2025
Co-delivery of anti-inflammatory and antioxidant agents via polymersomes for osteoarthritis therapyMengjie Rui, Li Wang, Ke Mi, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Pharmaceuticals (Basel, Switzerland)|August 28, 2025
Discovery of Small-Molecule PD-L1 Inhibitors via Virtual Screening and Their Immune-Mediated Anti-Tumor EffectsChunlai Feng, Yingying Ge, Siqi Wang, et al.
Drug Delivery|December 17, 2025
Tumor microenvironment-responsive conformational activation of apoA-I mimetic peptides for targeted cancer therapyMengjie Rui, Lei Fang, Mengfei Jia, et al.
International Journal of Biological Macromolecules|September 10, 2023
Design and evaluation of α-helix-based peptide inhibitors for blocking PD-1/PD-L1 interactionMengjie Rui, Wen Zhang, Ke Mi, et al.
Frontiers in Pharmacology|January 22, 2025
Artificial intelligence-driven identification and mechanistic exploration of synergistic anti-breast cancer compound combinations from <i>Prunella vulgaris</i> L.-<i>Taraxacum mongolicum</i> Hand.-Mazz. herb pairChunlai Feng, Jiaxi Cheng, Mengqiu Sun, et al.
AAPS Pharmscitech|February 11, 2025
Computational Design and Optimization of Multi-Compound Multivesicular Liposomes for Co-Delivery of Traditional Chinese Medicine CompoundsMengjie Rui, Yali Su, Haidan Tang, et al.
International Journal of Biological Macromolecules|June 20, 2024
In silico screening and in vivo experimental validation of 15-PGDH inhibitors from traditional Chinese medicine promoting liver regenerationChunlai Feng, Chunxue Qiao, Wei Ji, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Identification of Potential RBPJ-Specific Inhibitors for Blocking Notch Signaling in Breast Cancer Using a Drug Repurposing StrategyMengjie Rui, Min Cai, Yu Zhou, et al.
AAPS Pharmscitech|February 1, 2022
A Strategy for the Effective Optimization of Pharmaceutical Formulations Based on Parameter-Optimized Support Vector Machine ModelSiqi Wang, Jianping Yang, Hengwei Chen, et al.
International Journal of Pharmaceutics|June 14, 2017
Tumor-specific delivery of doxorubicin through conjugation of pH-responsive peptide for overcoming drug resistance in cancerChunlai Feng, Mengjie Rui, Haijun Shen, et al.
Frontiers in Pharmacology|July 24, 2025
Co-delivery of anti-inflammatory and antioxidant agents via polymersomes for osteoarthritis therapyMengjie Rui, Li Wang, Ke Mi, et al.
Pageof 4